Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR5 | P51681 | 20/20 | 0.80 |
| ▸ | CHRM2 | P08172 | 15/20 | 0.66 |
| ▸ | CHRM1 | P11229 | 5/20 | 0.66 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13481919 | 1.00 | CCR5 (0.80) | CCR5CHRM2CHRM1CHRM3 | |
| SCHEMBL13481545 | 0.93 | CCR5 (0.80) | CCR5CHRM2CHRM1CHRM3 | |
| SCHEMBL13481494 | 0.92 | CCR5 (0.79) | CCR5CHRM2CHRM1CHRM3 | |
| SCHEMBL13481969 | 0.92 | CCR5 (0.79) | CCR5CHRM2CHRM1CHRM3 | |
| SCHEMBL14032029 | 0.89 | CCR5 (0.85) | CCR5CHRM2CHRM1CHRM3 | |
| Vicriviroc SCHEMBL118885 | 0.89 | CCR5 (1.00) | CCR5CHRM2CHRM1CHRM3 | |
| Vicriviroc SCHEMBL15375740 | 0.89 | CCR5 (1.00) | CCR5CHRM2CHRM1CHRM3 | |
| Vicriviroc SCHEMBL4638191 | 0.89 | CCR5 (1.00) | CCR5CHRM2CHRM1CHRM3 | |
| Vicriviroc SCHEMBL4447817 | 0.89 | CCR5 (1.00) | CCR5CHRM2CHRM1CHRM3 | |
| SCHEMBL13481496 | 0.87 | CCR5 (0.71) | CCR5CHRM2CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7659275-B2 | treatment of HIV, solid organ transplant rejection, graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis | SCHERING CORPORATION (US) | 2010-02-09 | — | — | US | disclosed |